Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer

Breast cancer is a major health threat to women globally. Many circulating microRNAs are non-invasive cancer biomarkers. In this study, the expression of miR-29b and miR-31 was assessed in blood samples from 200 patients with breast cancer and wholesome volunteer women using quantitative reverse tra...

Full description

Bibliographic Details
Main Authors: Mona Ahmed Abbas, Ibrahim El Tantawy El Sayed, Azza Mohamed Kamel Abdu-Allah, Abul Kalam, Abdullah G. Al-Sehemi, Omar A. Al-Hartomy, Maha Salah Abd El-rahman
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2022-12-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054022000488
_version_ 1827280522224599040
author Mona Ahmed Abbas
Ibrahim El Tantawy El Sayed
Azza Mohamed Kamel Abdu-Allah
Abul Kalam
Abdullah G. Al-Sehemi
Omar A. Al-Hartomy
Maha Salah Abd El-rahman
author_facet Mona Ahmed Abbas
Ibrahim El Tantawy El Sayed
Azza Mohamed Kamel Abdu-Allah
Abul Kalam
Abdullah G. Al-Sehemi
Omar A. Al-Hartomy
Maha Salah Abd El-rahman
author_sort Mona Ahmed Abbas
collection DOAJ
description Breast cancer is a major health threat to women globally. Many circulating microRNAs are non-invasive cancer biomarkers. In this study, the expression of miR-29b and miR-31 was assessed in blood samples from 200 patients with breast cancer and wholesome volunteer women using quantitative reverse transcriptase PCR to evaluate their role in the disease. MiR-29b was significantly overexpressed in patients compared to controls. Multivariate regression analysis showed that it was an established risk factor for relapse and mortality. MiR-31 was significantly under-expressed in patients. It was an established risk factor for relapse and was strongly associated with mortality. For the prediction of relapse, miR-29b had a sensitivity of 81.25% and a specificity of 88.24% at a cutoff of > 30.09, while miR-31 had a sensitivity of 87.50% and a specificity of 79.41% at a cutoff of 0.12. The specificity was enhanced to 100% by combining the values of miR-29b and miR-31. In predicting mortality, miR-29b exhibited a sensitivity of 90% and a specificity of 97.5% at a cutoff of > 48.10. At a cutoff of 0.119, miR-31 exhibited a sensitivity of 87.50% and a specificity of 79.41%. High miR-29b expression and low miR-31 expression were linked with a low survival rate. MiR-29b and miR-31 could be useful markers for predicting breast cancer relapse and mortality.
first_indexed 2024-04-11T18:51:04Z
format Article
id doaj.art-c6b863693301486a9974b0698544f255
institution Directory Open Access Journal
issn 2468-0540
language English
last_indexed 2024-04-24T08:42:33Z
publishDate 2022-12-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj.art-c6b863693301486a9974b0698544f2552024-04-16T15:16:24ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402022-12-0174248257Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancerMona Ahmed Abbas0Ibrahim El Tantawy El Sayed1Azza Mohamed Kamel Abdu-Allah2Abul Kalam3Abdullah G. Al-Sehemi4Omar A. Al-Hartomy5Maha Salah Abd El-rahman6Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia, EgyptDepartment of Chemistry, Faculty of Science, Menoufia University, Egypt; Corresponding author.Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia, Egypt; Medical Laboratory Department, College of Applied Medical Sciences, Taibah University, Yanbu, Saudi ArabiaResearch Center for Advanced Materials Science (RCAMS), King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Department of Chemistry, College of Science, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi ArabiaResearch Center for Advanced Materials Science (RCAMS), King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Department of Chemistry, College of Science, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi ArabiaDepartment of Physics, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi ArabiaDepartment of Chemistry, Faculty of Science, Menoufia University, EgyptBreast cancer is a major health threat to women globally. Many circulating microRNAs are non-invasive cancer biomarkers. In this study, the expression of miR-29b and miR-31 was assessed in blood samples from 200 patients with breast cancer and wholesome volunteer women using quantitative reverse transcriptase PCR to evaluate their role in the disease. MiR-29b was significantly overexpressed in patients compared to controls. Multivariate regression analysis showed that it was an established risk factor for relapse and mortality. MiR-31 was significantly under-expressed in patients. It was an established risk factor for relapse and was strongly associated with mortality. For the prediction of relapse, miR-29b had a sensitivity of 81.25% and a specificity of 88.24% at a cutoff of > 30.09, while miR-31 had a sensitivity of 87.50% and a specificity of 79.41% at a cutoff of 0.12. The specificity was enhanced to 100% by combining the values of miR-29b and miR-31. In predicting mortality, miR-29b exhibited a sensitivity of 90% and a specificity of 97.5% at a cutoff of > 48.10. At a cutoff of 0.119, miR-31 exhibited a sensitivity of 87.50% and a specificity of 79.41%. High miR-29b expression and low miR-31 expression were linked with a low survival rate. MiR-29b and miR-31 could be useful markers for predicting breast cancer relapse and mortality.http://www.sciencedirect.com/science/article/pii/S2468054022000488microRNABreast cancerBiomarkerqRT-PCRExpression
spellingShingle Mona Ahmed Abbas
Ibrahim El Tantawy El Sayed
Azza Mohamed Kamel Abdu-Allah
Abul Kalam
Abdullah G. Al-Sehemi
Omar A. Al-Hartomy
Maha Salah Abd El-rahman
Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
Non-coding RNA Research
microRNA
Breast cancer
Biomarker
qRT-PCR
Expression
title Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
title_full Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
title_fullStr Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
title_full_unstemmed Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
title_short Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
title_sort expression of mirna 29b and mirna 31 and their diagnostic and prognostic values in egyptian females with breast cancer
topic microRNA
Breast cancer
Biomarker
qRT-PCR
Expression
url http://www.sciencedirect.com/science/article/pii/S2468054022000488
work_keys_str_mv AT monaahmedabbas expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT ibrahimeltantawyelsayed expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT azzamohamedkamelabduallah expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT abulkalam expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT abdullahgalsehemi expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT omaraalhartomy expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer
AT mahasalahabdelrahman expressionofmirna29bandmirna31andtheirdiagnosticandprognosticvaluesinegyptianfemaleswithbreastcancer